Compare ARVN & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | EH |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 866.0M |
| IPO Year | 2018 | 2019 |
| Metric | ARVN | EH |
|---|---|---|
| Price | $10.13 | $9.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 4 |
| Target Price | $15.35 | ★ $21.85 |
| AVG Volume (30 Days) | ★ 670.7K | 617.4K |
| Earning Date | 04-30-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $53.34 |
| Revenue Next Year | N/A | $75.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $9.67 |
| 52 Week High | $14.22 | $21.46 |
| Indicator | ARVN | EH |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 29.32 |
| Support Level | $9.02 | N/A |
| Resistance Level | $10.18 | $18.81 |
| Average True Range (ATR) | 0.67 | 0.54 |
| MACD | -0.22 | -0.18 |
| Stochastic Oscillator | 4.18 | 0.97 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.